Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Uterine Cervical Neoplasms × fosaprepitant × Clear all

Sponsor

Conditions

Vomiting 6 Nausea 3 Neoplasms 2 Uterine Neoplasms 1 Testicular Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Ovarian Neoplasms 1 Neoplasms, Germ Cell and Embryonal 1 Multiple Myeloma 1 Melanoma 1 Gynecologic Cancer 1 Gastrointestinal Neoplasms 1 Carcinoma, Renal Cell 1

Interventions

Cisplatin 28 human papillomavirus vaccine, L1 type 16, 18 16 Brachytherapy 13 Bevacizumab 11 Paclitaxel 10 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 10 Platinum 9 1,2-diaminocyclohexaneplatinum II citrate 9 Topotecan 8 Radiation 8 Papillomavirus Vaccines 8 Radiotherapy, Intensity-Modulated 7 pembrolizumab 6 Cyclophosphamide 6 tisotumab vedotin 5 fludarabine phosphate 5 fludarabine 5 aldesleukin 5 Radiotherapy 5 Magnetic Resonance Spectroscopy 5 Gemcitabine 5 Fluorodeoxyglucose F18 5 Carboplatin 5 atezolizumab 4 Vaccines, Synthetic 4 Taxes 4 Nivolumab 4 Colposcopy 4 Tobacco Use Cessation Devices 3 Surveys and Questionnaires 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡